Year |
Citation |
Score |
2012 |
Bui P, Solaimani P, Wu X, Hankinson O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicology and Applied Pharmacology. 259: 143-51. PMID 22230337 DOI: 10.1016/J.Taap.2011.12.009 |
0.722 |
|
2012 |
Bebenek IG, Solaimani P, Bui P, Hankinson O. CYP2S1 is negatively regulated by corticosteroids in human cell lines. Toxicology Letters. 209: 30-4. PMID 22155357 DOI: 10.1016/J.Toxlet.2011.11.020 |
0.664 |
|
2011 |
Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. European Journal of Pharmacology. 659: 30-6. PMID 21256842 DOI: 10.1016/J.Ejphar.2011.01.004 |
0.634 |
|
2011 |
Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 180-90. PMID 21068195 DOI: 10.1124/Dmd.110.035121 |
0.712 |
|
2010 |
Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Molecular Pharmacology. 78: 608-16. PMID 20631054 DOI: 10.1124/Mol.110.064899 |
0.725 |
|
2009 |
Bui PH, Hankinson O. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Molecular Pharmacology. 76: 1031-43. PMID 19713358 DOI: 10.1124/Mol.109.057752 |
0.715 |
|
2009 |
Bui PH, Hsu EL, Hankinson O. Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Molecular Pharmacology. 76: 1044-52. PMID 19713357 DOI: 10.1124/Mol.109.057760 |
0.738 |
|
2009 |
Beedanagari SR, Bebenek I, Bui P, Hankinson O. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 110: 61-7. PMID 19376845 DOI: 10.1093/Toxsci/Kfp079 |
0.658 |
|
2008 |
Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1291-9. PMID 18411403 DOI: 10.1124/Dmd.107.020115 |
0.615 |
|
Show low-probability matches. |